Kristen Hege

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi, Larry D. Anderson, Nina Shah et al. · New England Journal of Medicine · 2021 · 2.3K citations · Full text

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells

John Scholler, Troy Brady, Gwendolyn Binder-Scholl et al. · Science Translational Medicine · 2012 · 640 citations · Full text

Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects

Ronald T. Mitsuyasu, Peter A. Anton, Steven G. Deeks et al. · Blood · 2000 · 404 citations

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Mehmet Samur, Mariateresa Fulciniti, Anıl Aktaş Samur et al. · Nature Communications · 2021 · 388 citations · Full text